Details of the Drug | DrugMAP

General Information of Drug (ID: DMERIP9)

Drug Name

MK-8998

Indication

Disease Entry	ICD 11	Status	REF
Schizophrenia	6A20	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C20H23F3N2O2
Canonical SMILES: CC(C)C1=CC=C(C=C1)CC(=O)NC(C)C2=NC=C(C=C2)OCC(F)(F)F
InChI: 1S/C20H23F3N2O2/c1-13(2)16-6-4-15(5-7-16)10-19(26)25-14(3)18-9-8-17(11-24-18)27-12-20(21,22)23/h4-9,11,13-14H,10,12H2,1-3H3,(H,25,26)/t14-/m1/s1
InChIKey: IQIKXZMPPBEWAD-CQSZACIVSA-N

Cross-matching ID

PubChem CID: 24765479
CAS Number: 953778-58-0
TTD ID: D0F4GF

References

1	ClinicalTrials.gov (NCT00827918) A Study to Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004). U.S. National Institutes of Health.